In recent years, there has been a growing interest in psychedelic medicine as a potential breakthrough in mental health treatment. Canada, known for its progressive stance on cannabis, has emerged as a hotbed for psychedelic research and development. This has paved the way for investors to explore the burgeoning field of psychedelic mushroom stocks.
